Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Tauopathies Treatment Market Growth (Status and Outlook) 2022-2028

  • LP 4929756
  • 61 Pages
  • March 2022
  • Medical Devices
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Tauopathies Treatment will have significant change from previous year. According to our (LP Information) latest study, the global Tauopathies Treatment market size is USD million in 2022 from USD 791.3 million in 2021, with a change of % between 2021 and 2022. The global Tauopathies Treatment market size will reach USD 1437.4 million in 2028, growing at a CAGR of 8.9% over the analysis period.

The United States Tauopathies Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Tauopathies Treatment market, reaching US$ million by the year 2028. As for the Europe Tauopathies Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Tauopathies Treatment players cover Bristol-Myers Squibb Company, Selvita S.A, SK Biopharmaceuticals Co., Ltd., and Chronos Therapeutics Limited, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Tauopathies Treatment market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

SEL-141

RDC-5

YM-08

Thiamet-G

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Clinic

Hospital

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Bristol-Myers Squibb Company

Selvita S.A

SK Biopharmaceuticals Co., Ltd.

Chronos Therapeutics Limited

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Tauopathies Treatment Market Size 2017-2028

2.1.2 Tauopathies Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Tauopathies Treatment Segment by Type

2.2.1 SEL-141

2.2.2 RDC-5

2.2.3 YM-08

2.2.4 Thiamet-G

2.2.5 Others

2.3 Tauopathies Treatment Market Size by Type

2.3.1 Tauopathies Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Tauopathies Treatment Market Size Market Share by Type (2017-2022)

2.4 Tauopathies Treatment Segment by Application

2.4.1 Clinic

2.4.2 Hospital

2.4.3 Others

2.5 Tauopathies Treatment Market Size by Application

2.5.1 Tauopathies Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Tauopathies Treatment Market Size Market Share by Application (2017-2022)

3 Tauopathies Treatment Market Size by Player

3.1 Tauopathies Treatment Market Size Market Share by Players

3.1.1 Global Tauopathies Treatment Revenue by Players (2020-2022)

3.1.2 Global Tauopathies Treatment Revenue Market Share by Players (2020-2022)

3.2 Global Tauopathies Treatment Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Tauopathies Treatment by Regions

4.1 Tauopathies Treatment Market Size by Regions (2017-2022)

4.2 Americas Tauopathies Treatment Market Size Growth (2017-2022)

4.3 APAC Tauopathies Treatment Market Size Growth (2017-2022)

4.4 Europe Tauopathies Treatment Market Size Growth (2017-2022)

4.5 Middle East & Africa Tauopathies Treatment Market Size Growth (2017-2022)

5 Americas

5.1 Americas Tauopathies Treatment Market Size by Country (2017-2022)

5.2 Americas Tauopathies Treatment Market Size by Type (2017-2022)

5.3 Americas Tauopathies Treatment Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Tauopathies Treatment Market Size by Region (2017-2022)

6.2 APAC Tauopathies Treatment Market Size by Type (2017-2022)

6.3 APAC Tauopathies Treatment Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Tauopathies Treatment by Country (2017-2022)

7.2 Europe Tauopathies Treatment Market Size by Type (2017-2022)

7.3 Europe Tauopathies Treatment Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Tauopathies Treatment by Region (2017-2022)

8.2 Middle East & Africa Tauopathies Treatment Market Size by Type (2017-2022)

8.3 Middle East & Africa Tauopathies Treatment Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Tauopathies Treatment Market Forecast

10.1 Global Tauopathies Treatment Forecast by Regions (2023-2028)

10.1.1 Global Tauopathies Treatment Forecast by Regions (2023-2028)

10.1.2 Americas Tauopathies Treatment Forecast

10.1.3 APAC Tauopathies Treatment Forecast

10.1.4 Europe Tauopathies Treatment Forecast

10.1.5 Middle East & Africa Tauopathies Treatment Forecast

10.2 Americas Tauopathies Treatment Forecast by Country (2023-2028)

10.2.1 United States Tauopathies Treatment Market Forecast

10.2.2 Canada Tauopathies Treatment Market Forecast

10.2.3 Mexico Tauopathies Treatment Market Forecast

10.2.4 Brazil Tauopathies Treatment Market Forecast

10.3 APAC Tauopathies Treatment Forecast by Region (2023-2028)

10.3.1 China Tauopathies Treatment Market Forecast

10.3.2 Japan Tauopathies Treatment Market Forecast

10.3.3 Korea Tauopathies Treatment Market Forecast

10.3.4 Southeast Asia Tauopathies Treatment Market Forecast

10.3.5 India Tauopathies Treatment Market Forecast

10.3.6 Australia Tauopathies Treatment Market Forecast

10.4 Europe Tauopathies Treatment Forecast by Country (2023-2028)

10.4.1 Germany Tauopathies Treatment Market Forecast

10.4.2 France Tauopathies Treatment Market Forecast

10.4.3 UK Tauopathies Treatment Market Forecast

10.4.4 Italy Tauopathies Treatment Market Forecast

10.4.5 Russia Tauopathies Treatment Market Forecast

10.5 Middle East & Africa Tauopathies Treatment Forecast by Region (2023-2028)

10.5.1 Egypt Tauopathies Treatment Market Forecast

10.5.2 South Africa Tauopathies Treatment Market Forecast

10.5.3 Israel Tauopathies Treatment Market Forecast

10.5.4 Turkey Tauopathies Treatment Market Forecast

10.5.5 GCC Countries Tauopathies Treatment Market Forecast

10.6 Global Tauopathies Treatment Forecast by Type (2023-2028)

10.7 Global Tauopathies Treatment Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Bristol-Myers Squibb Company

11.1.1 Bristol-Myers Squibb Company Company Information

11.1.2 Bristol-Myers Squibb Company Tauopathies Treatment Product Offered

11.1.3 Bristol-Myers Squibb Company Tauopathies Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Bristol-Myers Squibb Company Main Business Overview

11.1.5 Bristol-Myers Squibb Company Latest Developments

11.2 Selvita S.A

11.2.1 Selvita S.A Company Information

11.2.2 Selvita S.A Tauopathies Treatment Product Offered

11.2.3 Selvita S.A Tauopathies Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Selvita S.A Main Business Overview

11.2.5 Selvita S.A Latest Developments

11.3 SK Biopharmaceuticals Co., Ltd.

11.3.1 SK Biopharmaceuticals Co., Ltd. Company Information

11.3.2 SK Biopharmaceuticals Co., Ltd. Tauopathies Treatment Product Offered

11.3.3 SK Biopharmaceuticals Co., Ltd. Tauopathies Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 SK Biopharmaceuticals Co., Ltd. Main Business Overview

11.3.5 SK Biopharmaceuticals Co., Ltd. Latest Developments

11.4 Chronos Therapeutics Limited

11.4.1 Chronos Therapeutics Limited Company Information

11.4.2 Chronos Therapeutics Limited Tauopathies Treatment Product Offered

11.4.3 Chronos Therapeutics Limited Tauopathies Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Chronos Therapeutics Limited Main Business Overview

11.4.5 Chronos Therapeutics Limited Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Tauopathies Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of SEL-141

Table 3. Major Players of RDC-5

Table 4. Major Players of YM-08

Table 5. Major Players of Thiamet-G

Table 6. Major Players of Others

Table 7. Tauopathies Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Tauopathies Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 9. Global Tauopathies Treatment Market Size Market Share by Type (2017-2022)

Table 10. Tauopathies Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 11. Global Tauopathies Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 12. Global Tauopathies Treatment Market Size Market Share by Application (2017-2022)

Table 13. Global Tauopathies Treatment Revenue by Players (2020-2022) & ($ Millions)

Table 14. Global Tauopathies Treatment Revenue Market Share by Player (2020-2022)

Table 15. Tauopathies Treatment Key Players Head office and Products Offered

Table 16. Tauopathies Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 17. New Products and Potential Entrants

Table 18. Mergers & Acquisitions, Expansion

Table 19. Global Tauopathies Treatment Market Size by Regions 2017-2022 & ($ Millions)

Table 20. Global Tauopathies Treatment Market Size Market Share by Regions (2017-2022)

Table 21. Americas Tauopathies Treatment Market Size by Country (2017-2022) & ($ Millions)

Table 22. Americas Tauopathies Treatment Market Size Market Share by Country (2017-2022)

Table 23. Americas Tauopathies Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 24. Americas Tauopathies Treatment Market Size Market Share by Type (2017-2022)

Table 25. Americas Tauopathies Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 26. Americas Tauopathies Treatment Market Size Market Share by Application (2017-2022)

Table 27. APAC Tauopathies Treatment Market Size by Region (2017-2022) & ($ Millions)

Table 28. APAC Tauopathies Treatment Market Size Market Share by Region (2017-2022)

Table 29. APAC Tauopathies Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 30. APAC Tauopathies Treatment Market Size Market Share by Type (2017-2022)

Table 31. APAC Tauopathies Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 32. APAC Tauopathies Treatment Market Size Market Share by Application (2017-2022)

Table 33. Europe Tauopathies Treatment Market Size by Country (2017-2022) & ($ Millions)

Table 34. Europe Tauopathies Treatment Market Size Market Share by Country (2017-2022)

Table 35. Europe Tauopathies Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 36. Europe Tauopathies Treatment Market Size Market Share by Type (2017-2022)

Table 37. Europe Tauopathies Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 38. Europe Tauopathies Treatment Market Size Market Share by Application (2017-2022)

Table 39. Middle East & Africa Tauopathies Treatment Market Size by Region (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Tauopathies Treatment Market Size Market Share by Region (2017-2022)

Table 41. Middle East & Africa Tauopathies Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Tauopathies Treatment Market Size Market Share by Type (2017-2022)

Table 43. Middle East & Africa Tauopathies Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 44. Middle East & Africa Tauopathies Treatment Market Size Market Share by Application (2017-2022)

Table 45. Key Market Drivers & Growth Opportunities of Tauopathies Treatment

Table 46. Key Market Challenges & Risks of Tauopathies Treatment

Table 47. Key Industry Trends of Tauopathies Treatment

Table 48. Global Tauopathies Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 49. Global Tauopathies Treatment Market Size Market Share Forecast by Regions (2023-2028)

Table 50. Global Tauopathies Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 51. Global Tauopathies Treatment Market Size Market Share Forecast by Type (2023-2028)

Table 52. Global Tauopathies Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 53. Global Tauopathies Treatment Market Size Market Share Forecast by Application (2023-2028)

Table 54. Bristol-Myers Squibb Company Details, Company Type, Tauopathies Treatment Area Served and Its Competitors

Table 55. Bristol-Myers Squibb Company Tauopathies Treatment Product Offered

Table 56. Bristol-Myers Squibb Company Tauopathies Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 57. Bristol-Myers Squibb Company Main Business

Table 58. Bristol-Myers Squibb Company Latest Developments

Table 59. Selvita S.A Details, Company Type, Tauopathies Treatment Area Served and Its Competitors

Table 60. Selvita S.A Tauopathies Treatment Product Offered

Table 61. Selvita S.A Main Business

Table 62. Selvita S.A Tauopathies Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 63. Selvita S.A Latest Developments

Table 64. SK Biopharmaceuticals Co., Ltd. Details, Company Type, Tauopathies Treatment Area Served and Its Competitors

Table 65. SK Biopharmaceuticals Co., Ltd. Tauopathies Treatment Product Offered

Table 66. SK Biopharmaceuticals Co., Ltd. Main Business

Table 67. SK Biopharmaceuticals Co., Ltd. Tauopathies Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 68. SK Biopharmaceuticals Co., Ltd. Latest Developments

Table 69. Chronos Therapeutics Limited Details, Company Type, Tauopathies Treatment Area Served and Its Competitors

Table 70. Chronos Therapeutics Limited Tauopathies Treatment Product Offered

Table 71. Chronos Therapeutics Limited Main Business

Table 72. Chronos Therapeutics Limited Tauopathies Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 73. Chronos Therapeutics Limited Latest Developments

List of Figures

Figure 1. Tauopathies Treatment Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Tauopathies Treatment Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Tauopathies Treatment Market Size Market Share by Type in 2021

Figure 7. Tauopathies Treatment in Clinic

Figure 8. Global Tauopathies Treatment Market: Clinic (2017-2022) & ($ Millions)

Figure 9. Tauopathies Treatment in Hospital

Figure 10. Global Tauopathies Treatment Market: Hospital (2017-2022) & ($ Millions)

Figure 11. Tauopathies Treatment in Others

Figure 12. Global Tauopathies Treatment Market: Others (2017-2022) & ($ Millions)

Figure 13. Global Tauopathies Treatment Market Size Market Share by Application in 2021

Figure 14. Global Tauopathies Treatment Revenue Market Share by Player in 2021

Figure 15. Global Tauopathies Treatment Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Tauopathies Treatment Market Size 2017-2022 ($ Millions)

Figure 17. APAC Tauopathies Treatment Market Size 2017-2022 ($ Millions)

Figure 18. Europe Tauopathies Treatment Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Tauopathies Treatment Market Size 2017-2022 ($ Millions)

Figure 20. Americas Tauopathies Treatment Value Market Share by Country in 2021

Figure 21. Americas Tauopathies Treatment Consumption Market Share by Type in 2021

Figure 22. Americas Tauopathies Treatment Market Size Market Share by Application in 2021

Figure 23. United States Tauopathies Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Tauopathies Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Tauopathies Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Tauopathies Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Tauopathies Treatment Market Size Market Share by Region in 2021

Figure 28. APAC Tauopathies Treatment Market Size Market Share by Application in 2021

Figure 29. China Tauopathies Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Tauopathies Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Tauopathies Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Tauopathies Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Tauopathies Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Tauopathies Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Tauopathies Treatment Market Size Market Share by Country in 2021

Figure 36. Europe Tauopathies Treatment Market Size Market Share by Type in 2021

Figure 37. Europe Tauopathies Treatment Market Size Market Share by Application in 2021

Figure 38. Germany Tauopathies Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Tauopathies Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Tauopathies Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Tauopathies Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Tauopathies Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Tauopathies Treatment Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Tauopathies Treatment Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Tauopathies Treatment Market Size Market Share by Application in 2021

Figure 46. Egypt Tauopathies Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Tauopathies Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Tauopathies Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Tauopathies Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Tauopathies Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Tauopathies Treatment Market Size 2023-2028 ($ Millions)

Figure 52. APAC Tauopathies Treatment Market Size 2023-2028 ($ Millions)

Figure 53. Europe Tauopathies Treatment Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Tauopathies Treatment Market Size 2023-2028 ($ Millions)

Figure 55. United States Tauopathies Treatment Market Size 2023-2028 ($ Millions)

Figure 56. Canada Tauopathies Treatment Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Tauopathies Treatment Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Tauopathies Treatment Market Size 2023-2028 ($ Millions)

Figure 59. China Tauopathies Treatment Market Size 2023-2028 ($ Millions)

Figure 60. Japan Tauopathies Treatment Market Size 2023-2028 ($ Millions)

Figure 61. Korea Tauopathies Treatment Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Tauopathies Treatment Market Size 2023-2028 ($ Millions)

Figure 63. India Tauopathies Treatment Market Size 2023-2028 ($ Millions)

Figure 64. Australia Tauopathies Treatment Market Size 2023-2028 ($ Millions)

Figure 65. Germany Tauopathies Treatment Market Size 2023-2028 ($ Millions)

Figure 66. France Tauopathies Treatment Market Size 2023-2028 ($ Millions)

Figure 67. UK Tauopathies Treatment Market Size 2023-2028 ($ Millions)

Figure 68. Italy Tauopathies Treatment Market Size 2023-2028 ($ Millions)

Figure 69. Russia Tauopathies Treatment Market Size 2023-2028 ($ Millions)

Figure 70. Spain Tauopathies Treatment Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Tauopathies Treatment Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Tauopathies Treatment Market Size 2023-2028 ($ Millions)

Figure 73. Israel Tauopathies Treatment Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Tauopathies Treatment Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Tauopathies Treatment Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450